We studied the effects of cuprammonium rayon (CR), polyacrylonitrile (PAN), polysulfone (PS), changes in osmolality, and heparin dosage on beta-2-microglobulin (b2M) handling in an in-vitro model that excluded convective transport and minimized diffusive transport. Both PAN and PS exhibited high adsorption capacity for b2M. Osmolality changes had no effect on b2M adsorption or release. CR membrane adsorption was minimal but increased slightly when higher heparin doses were used. In experiments with CR and high heparin doses (4 U/ml) b2M release occurred during the first 15 minutes of in-vitro dialysis, but this increase was inhibited by removing the leukocytes from the blood, indicating that b2M is released from leukocytes.
KachelH.G., AltmeyerP., BaldamusC.A., KochK.M.Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. Contr Nephrol1983; 36: 127–32.
2.
SpertiniF., WautersJ.P., PoulenasI.Carpal tunnel syndrome: a frequent, invalidating, longterm complication of chronic hemodialysis. Clin Nephrol1984; 21: 98–101.
3.
SchwarzA., KellerF., SeyfertS., PöllW., MolzahnM., DistlerA.Carpal tunnel syndrome: a major complication in long-term hemodialysis patients. Clin Nephrol1984; 22: 133–7.
4.
AssenatH., CalemardE., CharraB., LaurentG., TerratC., VanelT.Hémodialyse, syndrome du canal carpien et substance amyloïde. Nouv Press Médicale1980; 9: 1715.
5.
GejyoF., OdaniS., YamadaT.Beta-2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int1986; 30: 385–90.
6.
GorevicP., CaseyT., StoneW., Di RaimondoC., PrelliF., FrangioneB.Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest1985; 76: 2425–9.
7.
GejyoF., YamadaT., OdaniS.A new form of amyloid associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem Biophys Res1985; 129: 701–6.
8.
ShirahamaT., SkinnerM., CohenA.S.Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta-2-microglobulin. Lab Invest1985; 53: 705.
9.
ConnorsL.H., ShirahamaT., SkinnerM., FenvesA., CohenA.S.In vitro formation of amyloid fibrils from intact beta-2-microglobulin. Biochem. Biophys Res1985; 131: 1063–8.
DiRaimondoC.R., CaseyT.T., DiRaimondoC.V., StoneW.J.Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron1986; 43: 22–7.
SethiD., GowerP.Synovial fluid beta-2-microglobulin levels in dialysis arthropathy. N Engl J Med1986; 315: 1419–20.
16.
RöckelA., GilgeU., LiewaldA., HeidlandA.Elimination of low molecular weight proteins during hemofiltration. Artif Organs1982; 6: 307–11.
17.
RöckelA., HertelJ., FiegelP., AbdelhamidS., PanitzP., WalbD.Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int1986; 30: 429–32.
18.
BommerJ., SeeligP., SeeligR., GeerlingsW., BommerG., RitzE.Determinations of plasma beta-2-microglobulin concentrations: possible relation to membrane biocompatibility. Nephrol Dial Transplant1987; 2: 22–5.
FloegeJ., GranollerasC., ShaldonS., KochK.M.Beta-2-microglobulin kinetics with different dialysis membranes. Gambro Symposium: arthropathies des dialyses et amylose b2M. Paris, 1987; 101–4.
21.
AkizawaT., KitaokaT., KoshikawaS.Development of a regenerated cellulose non-complement activating membrane for hemodialysis, Trans Am Soc Artif Intern Organs1986; 32: 76–80.
